Reimagining Biologically Adapted Somatostatin Receptor-Targeted Radionuclide Therapy: Perspectives Based on Personal Experience and Observations on Recent Trials
J Nucl Med
.
2024 Sep 19:jnumed.124.268136.
doi: 10.2967/jnumed.124.268136.
Online ahead of print.
Authors
David Taïeb
1
2
,
Desirée Deandreis
3
,
Rodney J Hicks
4
5
Affiliations
1
Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France; david.taieb@ap-hm.fr.
2
ERL INSERM U1326 "RNAnoTher", CNRS, Aix-Marseille University, Marseille, France.
3
Gustave Roussy, University of Paris-Saclay, Villejuif, France.
4
Department of Medicine, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia; and.
5
Department of Medicine, Central Clinical School, Alfred Hospital, Monash University, Melbourne, Victoria, Australia.
PMID:
39299784
DOI:
10.2967/jnumed.124.268136
No abstract available
Publication types
Editorial